biopharma companies: Expect Syngene revenue to grow from high single digits to low double digits next year: Jonathan Hunt

Jonathan Hunt, MD & CEO, Syngene International, says the company deployed $55 million last year. Next year, they will be a little bit ahead of that – about $60 million. There are the usual themes within their business – automation, digitisation, improving productivity through an upgrading of technologies. About half of that should go towards …

Read more

power sector: Don’t foresee absolute power supply constraint current year: CARE Ratings

Sabyasachi Majumdar, Senior Director, CARE Ratings, the power sector is expected to have ample availability of electricity from thermal, gas, wind, and solar sources. The assurance lies in the willingness of distribution companies to pay for the power they receive. The current season is particularly favorable for wind and solar power generation. Unlike the supply …

Read more

eveready: When we are double the size of our turnover today, flashlights and lighting should be more than 50%: Eveready Industries MD

Suvamoy Saha, MD, Eveready Industries, says expects maximum growth from the lighting and electrical segment that they entered much later than other two segments. We remain committed to growing this vertical at a pace much faster than the rest of the company. Due to the significant price erosion, we landed up with a low level …

Read more